We are live on ! Find out more
MMPI

Morgenthaler Management Partners IX Portfolio holdings

AUM $22.6M
This Fund
S&P 500
This Quarter Est. Return
+1.08%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$125M
AUM Growth
–
Cap. Flow
+$113M
Cap. Flow %
90.65%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$56.6M
2
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$39.2M
3
VAPO
Vapotherm, Inc. Common Stock
VAPO
+$17.7M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRNB
1
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$60.1M 48.03%
+2,195,125
New +$56.6M
RARX
2
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$45.5M 36.31%
+2,497,552
New +$39.2M
VAPO
3
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$19.6M 15.66%
+122,836
New +$17.7M

Similar funds

DPA
Delphi Private Advisors San Diego, California $19.6M AUM 1.25% 1-Year Est. Return
HCA
Hillview Capital Advisors Wayne, Pennsylvania $18.8M AUM 1.7% 1-Year Est. Return
TCM
TVR Capital Management Stamford, Connecticut $16.3M AUM 45.87% 1-Year Est. Return
AC
Argentiere Capital Zug, Switzerland $15.4M AUM 8.82% 1-Year Est. Return
MP
Manifold Partners San Francisco, California $10.4M AUM 5.49% 1-Year Est. Return
WAM
WIM Asset Management Hong Kong $35.6M AUM
AF
Aristotle Fund Portland, Maine $6.27M AUM 17.13% 1-Year Est. Return
KAM
Kassirer Asset Management Toronto, Ontario, Canada $4.07M AUM 49.71% 1-Year Est. Return

Morgenthaler Management Partners IX's Q4 2018 Portfolio in Review

Q4 2018 is the first quarter with a 13F filing on record for Morgenthaler Management Partners IX, which disclosed 3 positions worth $125M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Principia Biopharma Inc. Common Stock: 2,195,125 shares worth $60.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Morgenthaler Management Partners IX's largest Q4 2018 buy was Principia Biopharma Inc. Common Stock: 2,195,125 shares worth $60.1M.
  • Morgenthaler Management Partners IX's ten largest holdings make up 100% of its $125M portfolio in Q4 2018.
  • Morgenthaler Management Partners IX disclosed 3 positions in Q4 2018, its first 13F filing on record.

Based on Morgenthaler Management Partners IX's 13F filing for Q4 2018, filed 14 Feb 2019.